Alivus Life Sciences Ltd. (GLS)
Market Closed
16 Oct, 10:00 AM
XNSE MSE Primary XNSE ₹
1,309. 50
-32.3
-2.4072%
₹
- Market Cap
- P/E Ratio
- Div Yield
35,946 Volume
- Eps
₹ 1,341.8
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
GLS closed Friday lower at ₹1,309.5, a decrease of -2.4072% from Thursday's close, completing a monthly decrease of -4.7151% or -₹64.8. Over the past 12 months, GLS stock gained 42.8649%.
GLS is not paying dividends to its shareholders.
The last earnings report, released on Apr 25, 2024, missed the consensus estimates by -2.43%. On average, the company has surpassed earnings expectations by 1.71%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).
GLS Chart
Alivus Life Sciences Ltd. (GLS) FAQ
What is the stock price today?
The current price is ₹1,309.50.
On which exchange is it traded?
Alivus Life Sciences Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is GLS.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Alivus Life Sciences Ltd. ever had a stock split?
No, there has never been a stock split.
Alivus Life Sciences Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | - CEO | XNSE Exchange | INE03Q201024 ISIN |
| United Kingdom Country | - Employees | 17 Oct 2023 Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
2026 © Marketlog. All Rights Reserved.
